株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の抗肥満処方薬市場の分析・予測:2019年

China Anti-Obesity Prescription Drugs Market Research Report 2019

発行 QYResearch 商品コード 895763
出版日 ページ情報 英文 102 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
中国の抗肥満処方薬市場の分析・予測:2019年 China Anti-Obesity Prescription Drugs Market Research Report 2019
出版日: 2019年07月29日 ページ情報: 英文 102 Pages
概要

中国の抗肥満処方薬の市場は予測期間中3.90%のCAGR (年間複合成長率)で推移し、2018年の5520万米ドルから、2025年末には7253万米ドルの規模に成長すると予測されています。

当レポートでは、中国の抗肥満処方薬の市場を調査し、市場および製品の概要、販売数・収益・価格などの推移と予測、タイプ・用途・地域・企業別の詳細分析、市場への各種影響因子の分析、主要企業のプロファイルなどをまとめています。

第1章 製品範囲

  • 製品概要・調査対象
  • 市場分析:製品タイプ別
    • 販売数の比較
    • 市場シェア
    • OTC
    • Rx
  • 市場分析:用途・エンドユーザー別
    • 販売数・市場シェアの比較
    • 院内薬局
    • 小売薬局
    • Eコマース
  • 市場分析:地域別
  • 販売数・収益・成長率
  • マクロ指標

第2章 競合環境・製造業者

  • 販売数・市場シェア
  • 収益・市場シェア
  • 価格
  • 競合状況・動向
  • 本拠地・設立日・製品タイプ

第3章 市場の推移:地域別

  • 販売数・シェアの推移
  • 収益・シェアの推移
  • 価格の推移

第4章 市場の推移:地域別

  • 販売数・シェアの推移
  • 収益・シェアの推移
  • 価格の推移
  • 販売数の成長率の推移

第5章 市場の推移:用途別

  • 販売数・シェアの推移
  • 販売数の成長率の推移

第6章 主要製造業者の分析

  • Zhejiang Hisun
  • ZHIEN pharmaceutica
  • Lunan
  • Wanhan
  • Huadong Medicine
  • Roche

第7章 製造コストの分析

  • 原材料の分析
  • 製造コスト構造
  • 製造プロセス

第8章 産業チェーン・調達戦略・下流バイヤー

第9章 マーケティング戦略・流通販売業者

第10章 影響因子

  • 原材料の価格動向
  • 輸出入動向

第11章 市場予測

  • 販売数・収益の予測
  • 販売数の予測:タイプ別
  • 販売数の予測:用途別
  • 販売数の予測:地域別

第12章 調査結果・総論

第13章 調査手法・データソース

目次

This report studies the Anti-Obesity Prescription Drugs development status and future trend in China, focuses on top players in China, also splits Anti-Obesity Prescription Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The China Anti-Obesity Prescription Drugs market is valued at USD 55.20 million in 2018 and is expected to reach USD 72.53 million by the end of 2025, growing at a CAGR of 3.90% between 2019 and 2025.

The major players in global market include

Zhejiang Hisun

ZHIEN pharmaceutica

Lunan

Wanhan

Huadong Medicine

Roche

Other

Geographically, this report splits the China market into seven regions,

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

On the basis of product, the Anti-Obesity Prescription Drugs market is primarily split into

OTC

Rx

On the basis on the end users/applications, this report covers

Hospitals Pharmacies

Retail Pharmacies

E-commerce

Table of Contents

1 Anti-Obesity Prescription Drugs Overview 1

  • 1.1 Product Overview and Scope of Anti-Obesity Prescription Drugs 1
  • 1.2 Classification of Anti-Obesity Prescription Drugs by Product Category 2
    • 1.2.1 China Anti-Obesity Prescription Drugs Sales Comparison by Types (2014-2025) 2
    • 1.2.2 China Anti-Obesity Prescription Drugs Sales Market Share by Types in 2018 3
    • 1.2.3 OTC 4
    • 1.2.4 Rx 4
  • 1.3 China Anti-Obesity Prescription Drugs Market by Applications/End Users 5
    • 1.3.1 China Anti-Obesity Prescription Drugs Sales and Market Share Comparison by Applications (2014-2025) 5
    • 1.3.2 Hospitals Pharmacies 6
    • 1.3.3 Retail Pharmacies 7
    • 1.3.4 E-commerce 7
  • 1.4 China Anti-Obesity Prescription Drugs Market by Regions 8
    • 1.4.1 China Anti-Obesity Prescription Drugs Market Size (Million USD) Comparison by Regions (2014-2025) 8
    • 1.4.2 South China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 8
    • 1.4.3 East China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 9
    • 1.4.4 Southwest China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 10
    • 1.4.5 Northeast China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 11
    • 1.4.6 North China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 12
    • 1.4.7 Central China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 13
  • 1.5 China Market Size (Sales and Revenue) of Anti-Obesity Prescription Drugs (2014-2025) 14
    • 1.5.1 China Anti-Obesity Prescription Drugs Sales and Growth Rate (%) (2014-2025) 14
    • 1.5.2 China Anti-Obesity Prescription Drugs Revenue and Growth Rate (2014-2025) 14
  • 1.6 Macroscopic Indicator 16
    • 1.6.1 GDP for Major Regions 16
    • 1.6.2 Population and Labor Considered for Forecast 18
    • 1.6.3 Disposable Income Considered for Forecast 20

2 China Anti-Obesity Prescription Drugs Market Competition by Players/Manufacturers 22

  • 2.1 China Anti-Obesity Prescription Drugs Sales and Market Share of Key Players/Manufacturers (2018-2019) 22
  • 2.2 China Anti-Obesity Prescription Drugs Revenue and Share by Players/Manufacturers (2018-2019) 24
  • 2.3 China Anti-Obesity Prescription Drugs Average Price by Players/Manufacturers (2018-2019) 26
  • 2.4 China Anti-Obesity Prescription Drugs Market Competitive Situation and Trends 28
    • 2.4.1 China Anti-Obesity Prescription Drugs Market Concentration Ratec 28
    • 2.4.2 China Anti-Obesity Prescription Drugs Market Share of Top 3 and Top 5 Players/Manufacturers 29
    • 2.4.3 Mergers & Acquisitions, Expansion in China Market 30
  • 2.5 China Players/Manufacturers Anti-Obesity Prescription Drugs Headquarters, Established Date and Product Types 30

3 China Anti-Obesity Prescription Drugs Sales and Revenue by Regions (2014-2019) 32

  • 3.1 China Anti-Obesity Prescription Drugs Sales and Market Share by Regions (2014-2019) 32
  • 3.2 China Anti-Obesity Prescription Drugs Revenue and Market Share by Regions (2014-2019) 34
  • 3.3 China Anti-Obesity Prescription Drugs Price (USD/Unit) by Regions (2014-2019) 36

4 China Anti-Obesity Prescription Drugs Sales and Revenue by Type/ Product Category (2014-2019) 37

  • 4.1 China Anti-Obesity Prescription Drugs Sales and Market Share by Type/ Product Category (2014-2019) 37
  • 4.2 China Anti-Obesity Prescription Drugs Revenue (Million USD) and Market Share by Type (2014-2019) 39
  • 4.3 China Anti-Obesity Prescription Drugs Price (USD/Unit) by Type (2014-2019) 40
  • 4.4 China Anti-Obesity Prescription Drugs Sales Growth Rate by Type (2014-2019) 41

5 China Anti-Obesity Prescription Drugs Sales by Application (2014-2019) 42

  • 5.1 China Anti-Obesity Prescription Drugs Sales and Market Share by Applications (2014-2019) 42
  • 5.2 China Anti-Obesity Prescription Drugs Sales Growth Rate by Applications (2014-2019) 44

6 Analysis of Anti-Obesity Prescription Drugs Industry Key Manufacturers 45

  • 6.1 Zhejiang Hisun 45
    • 6.1.1 Company Profile 45
    • 6.1.2 Product Information 46
    • 6.1.3 Sales, Price, Revenue and Gross Margin 46
  • 6.2 ZHIEN pharmaceutica 47
    • 6.2.1 Company Profile 47
    • 6.2.2 Product Information 48
    • 6.2.3 Sales, Price, Revenue and Gross Margin 48
  • 6.3 Lunan 49
    • 6.3.1 Company Profile 49
    • 6.3.2 Product Information 50
    • 6.3.3 Sales, Price, Revenue and Gross Margin 50
  • 6.4 Wanhan 51
    • 6.4.1 Company Profile 51
    • 6.4.2 Product Information 52
    • 6.4.3 Sales, Price, Revenue and Gross Margin 52
  • 6.5 Huadong Medicine 53
    • 6.5.1 Company Profile 53
    • 6.5.2 Product Information 54
    • 6.5.3 Sales, Price, Revenue and Gross Margin 54
  • 6.6 Roche 55
    • 6.6.1 Company Profile 55
    • 6.6.2 Product Information 56
    • 6.6.3 Sales, Price, Revenue and Gross Margin 56

7 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis 57

  • 7.1 Anti-Obesity Prescription Drugs Key Raw Materials Analysis 57
    • 7.1.1 Key Raw Materials 57
    • 7.1.2 Key Suppliers of Raw Materials 57
  • 7.2 Proportion of Manufacturing Cost Structure 58
    • 7.2.1 Raw Materials 58
    • 7.2.2 Labor Cost 59
    • 7.2.3 Other Costs Analysis 60
    • 7.2.4 Manufacturing Expenses 61
  • 7.3 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs 62

8 Industrial Chain, Sourcing Strategy and Downstream Buyers 63

  • 8.1 Anti-Obesity Prescription Drugs Industrial Chain Analysis 63
  • 8.2 Upstream Raw Materials Sourcing 64
  • 8.3 Raw Materials Sources of Anti-Obesity Prescription Drugs Major Players/Manufacturers in 2018 64
  • 8.4 Downstream Buyers 65

9 Marketing Strategy Analysis, Distributors/Traders 66

  • 9.1 Marketing Channel 66
    • 9.1.1 Direct Marketing 68
    • 9.1.2 Indirect Marketing 68
    • 9.1.3 Marketing Channel Development Trend 68
  • 9.2 Market Positioning 69
    • 9.2.1 Pricing Strategy 69
    • 9.2.2 Brand Strategy 70
  • 9.3 Distributors/Traders List 71

10 Factors Influencing 73

  • 10.1 Price Trend of Key Industrial Raw Material 73
  • 10.2 Imports & Exports 74

11 China Anti-Obesity Prescription Drugs Market Size (Sales and Revenue) Forecast (2020-2025) 80

  • 11.1 China Anti-Obesity Prescription Drugs Sales, Revenue Forecast (2020-2025) 80
  • 11.2 China Anti-Obesity Prescription Drugs Sales Forecast by Type (2020-2025) 81
  • 11.3 China Anti-Obesity Prescription Drugs Sales Forecast by Application (2020-2025) 82
  • 11.4 China Anti-Obesity Prescription Drugs Sales Forecast by Regions (2020-2025) 83

12 Research Findings and Conclusion 86

13 Methodology and Data Source 87

  • 13.1 Methodology/Research Approach 87
    • 13.1.1 Research Programs/Design 87
    • 13.1.2 Market Size Estimation 88
    • 13.1.3 Market Breakdown and Data Triangulation 89
  • 13.2 Data Source 90
    • 13.2.1 Secondary Sources 90
    • 13.2.2 Primary Sources 91
  • 13.3 Author List 92
  • 13.4 Disclaimer 92
Back to Top